Clinical Report: Myopia's Rising Prevalence and Associated Societal Burdens
Overview
The rising prevalence of myopia poses significant societal burdens, impacting mental health, quality of life, and educational outcomes for children. Effective management strategies are essential to mitigate these effects and improve access to care.
Background
Myopia is increasingly recognized as a public health concern due to its growing prevalence, particularly among children. The condition not only affects vision but also has broader implications for mental health and educational achievement. Addressing myopia through effective management strategies is crucial for improving quality of life and reducing long-term societal costs.
Data Highlights
No specific numerical data was provided in the source material.
Key Findings
- Myopia prevalence is projected to approach 40% by 2050 among school-age populations.
- High myopia significantly increases the risk of visual impairment and associated economic burdens.
- Underserved populations face greater challenges in accessing myopia care due to provider shortages.
- Effective myopia management strategies include myopia-control spectacle lenses, dual-focus/multifocal contact lenses, and pharmacologic therapies.
- Public awareness and insurance coverage for myopia management are critical for improving access to care.
Clinical Implications
Healthcare providers should prioritize early identification and active management of myopia to prevent long-term complications. Increasing public awareness and advocating for insurance coverage can enhance access to necessary treatments, particularly in underserved communities.
Conclusion
Addressing the rising prevalence of myopia requires a multifaceted approach that includes effective management strategies and improved access to care. Collaborative efforts are essential to mitigate the societal impacts of this condition.
References
- British Journal of Ophthalmology, 2025 -- Global prevalence, trend and projection of myopia in children and adolescents from 1990 to 2050
- IMI—Interventions for Controlling Myopia Onset and Progression 2025
- Contact Lens Spectrum, 2026 -- Myopia Beyond 2025
- Contact Lens Spectrum — The Business of Contact Lenses
- Eyecare Business — Optometric Business Tracker
- Contact Lens Spectrum — Myopia Beyond 2025
- Global prevalence, trend and projection of myopia in children and adolescents from 1990 to 2050: a comprehensive systematic review and meta-analysis | British Journal of Ophthalmology
- IMI—Interventions for Controlling Myopia Onset and Progression 2025
- Atropine and Spectacle lens Combination Treatment (ASPECT): 12-month results of a randomised controlled trial for myopia control using a combination of Defocus Incorporated Multiple Segments (DIMS) lenses and 0.025% atropine | British Journal of Ophthalmology
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.


